Justice is coming. Devin Nunes Sending Criminal Referral

New Post Public Reply Private Reply Replies (1) Message Board
Lmcat
214
Justice is coming.

Devin Nunes Sending Criminal Referral to DOJ over Spygate: ‘Time to Go on Offense’

House Intelligence Committee Ranking Member Devin Nunes (R-CA) is planning to send a criminal referral next week to the Justice Department that will detail “multiple referrals on a number of different crimes,” including leaking classified information, as part of his investigation into misconduct at the Justice Department and the FBI.

“As of now, it’ll be one criminal referral but with multiple referrals on a number of different crimes,” he told Breitbart News on Wednesday in an exclusive interview. “We will have some leakers in there for sure.”

He said on the ending of the Special Counsel investigation, after it found the Trump campaign did not collude with Russia, “We knew this was a joke from the beginning, and I’ve said as much for a long time. Basically from the time our report came out, which has been a year. But now, the real work begins. It’s good to not have that sitting out there. But we have to now go on offense and track down all these dirty cops and bad players.”

In addition, Nunes said he plans to interview about 50 people—some who have never been called before Congress—who were involved or know about the pushing of the “pee dossier” within various U.S. government agencies, and its use to get a surveillance warrant on former Trump campaign adviser Carter Page.


Nunes—who took a beating from mainstream news outlets for challenging the Russian collusion narrative—wants to get to the bottom of how it all began, which he said was long before the FBI claims they officially began their investigation of the Trump campaign in late July 2016.

“It all stems from the fact that we know that this investigation started long before the end of July,” he said. “We are quite confident that this investigation started long before they told us that it did.”

He said it reaches all the way to the Obama White House, though it is not yet clear how involved former President Barack Obama was.


“Look, there’s big problems — big problems that the public needs to know about. Maximum transparency is the best thing here,” he said.

Nunes said he believes Barr will have to act on his criminal referral. “There’ll be things in there that cannot be ignored. There will be crimes … so they have to be dealt with,” he said.

He told Fox News on Tuesday he would target “people who lied to Congress, perjury, [and] criminal conspiracy.”

As far as his Democrat colleagues who have not given up on the idea that the Trump campaign colluded with Russia, he said, referring to the mythical beast, “These guys are chasing Chupacabra.”

“That really is what they’re looking for … unicorns, the Lochness monster—they’re interchangeable,” he said.

Nunes said the question of whether his Democrat colleague, Rep. Adam Schiff (D-CA), should resign as chairman of the House Intelligence Committee, should be directed to Democrat leadership.

“I’ll let our leadership speak to that. My job is to work with whoever is there. At the end of the day, [House Speaker Nancy] Pelosi makes the decision. But I’ll just say that I think more real journalists need to ask real questions to Team Chupacabra,” he said.

https://www.breitbart.com/politics/2019/03/27...e-offense/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 36

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 41

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 37

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 32

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Mobilize for Action Against Organon & Co. (OGN) Claims

Updated Category News Views 248

Mobilizing for Justice: Organon & Co. Class Action Lawsuit Overview Recent developments have drawn serious attention to Organon & Co. (NYSE: OGN), as investors set their sights on a class action lawsuit aimed at seeking justice for significant financial losses incurred. The legal proceedings are a reaction to purported misleading statements made by the company’s...

Continue Reading
Humana's 2024 Third Quarter Results Show Financial Resilience

Updated Category News Views 107

Humana Reports Third Quarter Financial Results for 2024 Humana Inc. (NYSE: HUM) has recently disclosed its consolidated financial results for the third quarter of 2024, highlighting a comprehensive overview of its performance compared to the previous year. Despite prevailing challenges within the healthcare sector, the organization showcased solid financial resilience and...

Continue Reading
CobbleStone Joins Civic Marketplace for Easy Gov't Procurement

Updated Category News Views 21

CobbleStone Software Goes Digital with Civic Marketplace Sometimes in this tech-driven world, it feels like the old-school bureaucratic processes just can't keep up. Enter CobbleStone Software, a name that's ringing bells in the halls of government offices with a neat little trick up its sleeve: integrating its contract management platform into the Civic Marketplace. It's...

Continue Reading
Shineco Inc Faces Stock Challenges Amid Recovery Efforts

Updated Category News Views 186

Shineco Inc Stock Experiences Significant Decline Shineco Inc (SISI) has reached a concerning milestone as its stock plummets to a 52-week low at $1.92. With a market capitalization of only $3.64 million, this dip reveals ongoing issues within the company's financial landscape. Analysts have pegged its financial health score as 'WEAK', bringing to light several risk...

Continue Reading
Epsilon Energy Reflects on Strategic Acquisitions in Oil and Gas

Updated Category News Views 254

Epsilon Energy’s Latest Strategic Acquisition Epsilon Energy Ltd. (NASDAQ: EPSN), a prominent player in North American onshore natural gas and oil production, has completed significant acquisitions, marking an important chapter in the company’s expansion strategy. Through the recent purchase of Peak Exploration and Production LLC and Peak BLM Lease LLC, referred to as...

Continue Reading